Fonepay and LankaPay Sign MOU for Cross-Border Interoperable Payment System
Kathmandu, Jun 2, 2023 – (ACN Newswire) – Fonepay, Nepal’s Largest Payment Network announced a…
Kathmandu, Jun 2, 2023 – (ACN Newswire) – Fonepay, Nepal’s Largest Payment Network announced a…
FAIRFIELD, N.J.–(BUSINESS WIRE)–DLA, LLC (DLA), a leading provider of internal audit and accounting advisory services,…
BUFFALO, N.Y.–(BUSINESS WIRE)–Columbus McKinnon Corporation (Nasdaq: CMCO), a leading designer, manufacturer and marketer of intelligent…
The first user of the Ultimate AI TechLuxury FF 91 vehicle has signed the first…
Wildwood at Laurel Ranch offers personalized, new homes close to desirable schools and outdoor recreation,…
BOSTON, June 02, 2023 (GLOBE NEWSWIRE) — Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage…
BOSTON, June 02, 2023 (GLOBE NEWSWIRE) — Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage…
Topline results using the Company’s SCI-110 met the trial’s primary and secondary end points, demonstrating…
Topline results using the Company’s SCI-110 met the trial’s primary and secondary end points, demonstrating…
CALGARY, Alberta, June 02, 2023 (GLOBE NEWSWIRE) — Providence Therapeutics Holdings Inc. (“Providence”), a biopharmaceutical…
CALGARY, Alberta, June 02, 2023 (GLOBE NEWSWIRE) — Providence Therapeutics Holdings Inc. (“Providence”), a biopharmaceutical…
XI’AN, China, June 02, 2023 (GLOBE NEWSWIRE) — Bon Natural Life Limited (Nasdaq: BON) (“BON”…
XI’AN, China, June 02, 2023 (GLOBE NEWSWIRE) — Bon Natural Life Limited (Nasdaq: BON) (“BON”…
BUFFALO, N.Y., June 02, 2023 (GLOBE NEWSWIRE) — 22nd Century Group, Inc. (Nasdaq: XXII), a…
BUFFALO, N.Y., June 02, 2023 (GLOBE NEWSWIRE) — 22nd Century Group, Inc. (Nasdaq: XXII), a…
HAMPTON, N.J., June 02, 2023 (GLOBE NEWSWIRE) — Celldex Therapeutics, Inc. (NASDAQ:CLDX) announced today that…
HAMPTON, N.J., June 02, 2023 (GLOBE NEWSWIRE) — Celldex Therapeutics, Inc. (NASDAQ:CLDX) announced today that…
Kisqali is the first and only CDK4/6 inhibitor to demonstrate a consistent, clinically meaningful benefit…
Kisqali is the first and only CDK4/6 inhibitor to demonstrate a consistent, clinically meaningful benefit…
CAMBRIDGE, Mass. and NEW YORK, June 02, 2023 (GLOBE NEWSWIRE) — Black Diamond Therapeutics, Inc….